Lacosamide Tablet, Film Coated
Product Images NDC 70518-4505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 70518-4505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Lacosamide Tablet C-V, 100 mg, film-coated tablets. The label indicates a quantity of 30 tablets, oval yellow in shape, marked with L424. The product is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Alembic Pharma, Bridgewater, NJ. Storage instructions and prescription-only status are noted.*

FDA Label Image

Figure1 (Lacosamide Figure 1)

A bar graph titled "Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose." It compares median percent reduction in seizure frequency among placebo and various dosages of Lacosamide in three clinical studies. The y-axis shows seizure frequency reduction percentage, ranging from 0% to 45%. The graph includes data from Study 2, Study 3, and Study 4, illustrating higher seizure frequency reductions in Lacosamide groups compared to placebo groups.*

FDA Label Image

Figure2 (Lacosamide Figure 2)

A line graph showing the proportion of patients by responder rate for Lacosamide and Placebo groups in studies 2, 3, and 4. The y-axis represents responder rate from -100% (worsening) to 100% (improvement), and the x-axis shows percent of patients. The graph includes four lines: Placebo (solid), Lacosamide 200 mg/day (long dash), 400 mg/day (short dash), and 600 mg/day (dash dot), depicting comparative patient response rates.*

FDA Label Image

Figure 3 (Lacosamide Figure3)

A Kaplan-Meier survival curve comparing the proportion of patients over time for placebo and lacosamide treatment groups. The graph shows the proportion of patients on the vertical axis and time on the horizontal axis, with separate step lines for placebo and lacosamide groups. Additional statistics such as p-value, hazard ratio, and confidence interval are noted on the graph.*

FDA Label Image

Structure (Lacosamide Str)

Chemical structure of lacosamide, showing the arrangement of atoms and bonds in the molecule. Key features include an acetylated amide group, a chiral center adjacent to a carbonyl group, a methoxy substituent, and a benzyl group attached to an amine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.